AG
RETA

Aperio Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Aperio Group’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.02M Buy
2020
Q3 		$581K Buy
2020
Q2 		$697K Buy
2020
Q1 		$562K Buy
2019
Q4 		$517K Buy
2019
Q3 		– Sell
2019
Q2 		$219K Buy